Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
TTP-ICG Fluorescent Probe for Ex Vivo Bladder Cancer Identification
NCT07848854Phase 2Recruiting
- Sponsor
- Yunnan Cancer Hospital
- Start
- Aug 2026
- Primary completion
- Jul 2027
- Countries
- 1
01
Overview
A Phase 2 trial of TTP-ICG in bladder cancer, urothelial carcinoma (UC), sponsored by Yunnan Cancer Hospital. Started Aug 2026; status: recruiting.
02
Drugs
TTP-ICG
03
Conditions
bladder cancerurothelial carcinoma (UC)
Beyond the preview
Go deeper on NCT07848854.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT07848854.